A new helicase assay based on graphene oxide for anti-viral drug development

被引:12
作者
Jang, Hongje [2 ]
Ryoo, Soo-Ryoon [1 ]
Lee, Min Jae [3 ]
Han, Sang Woo [2 ]
Min, Dal-Hee [1 ]
机构
[1] Seoul Natl Univ, Dept Chem, Inst Basic Sci, Seoul 151747, South Korea
[2] Korea Adv Inst Sci & Technol, Dept Chem, Inst Basic Sci, Ctr Nanomat & Chem React, Taejon 305701, South Korea
[3] Kyung Hee Univ, Dept Appl Chem, Yongin 446701, South Korea
基金
新加坡国家研究基金会;
关键词
biosensor; drug screening; graphene oxide; helicase; hepatitis C; NS3; HELICASE; RNA HELICASE; HEPATITIS; INHIBITORS; PLATFORM; BINDING; THERAPIES; RELEASE; PROTEIN; SIZE;
D O I
10.1007/s10059-013-0066-1
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Recently, graphene oxide (GO), one of the carbon nanomaterials, has received much attention due to its unique physical and chemical properties and high potential in many research areas, including applications as a biosensor and drug delivery vehicle. Various GO-based biosensors have been developed, largely based on its surface adsorption properties for detecting biomolecules, such as nucleotides and peptides, and real-time monitoring of enzymatic reactions. In this review, we discuss recent advances in GO-based biosensors focusing on a novel assay platform for helicase activity, which was also employed in high-throughput screening to discover selective helicase inhibitors.
引用
收藏
页码:269 / 273
页数:5
相关论文
共 44 条
[1]   A novel high throughput screening assay for HCVNS3 helicase activity [J].
Alaoui-Ismaili, MH ;
Gervais, C ;
Brunette, S ;
Gouin, G ;
Hamel, M ;
Rando, RF ;
Bedard, J .
ANTIVIRAL RESEARCH, 2000, 46 (03) :181-193
[2]   Monitoring helicase activity with molecular beacons [J].
Belon, Craig A. ;
Frick, David N. .
BIOTECHNIQUES, 2008, 45 (04) :433-+
[3]  
Borowski P, 2002, ACTA BIOCHIM POL, V49, P597
[4]   Graphene Fluorescence Resonance Energy Transfer Aptasensor for the Thrombin Detection [J].
Chang, Haixin ;
Tang, Longhua ;
Wang, Ying ;
Jiang, Jianhui ;
Li, Jinghong .
ANALYTICAL CHEMISTRY, 2010, 82 (06) :2341-2346
[5]   ISOLATION OF A CDNA CLONE DERIVED FROM A BLOOD-BORNE NON-A, NON-B VIRAL-HEPATITIS GENOME [J].
CHOO, QL ;
KUO, G ;
WEINER, AJ ;
OVERBY, LR ;
BRADLEY, DW ;
HOUGHTON, M .
SCIENCE, 1989, 244 (4902) :359-362
[6]   Challenges and successes in developing new therapies for hepatitis C [J].
De Francesco, R ;
Migliaccio, G .
NATURE, 2005, 436 (7053) :953-960
[7]   Time-resolved fluorescence energy transfer DNA helicase assays for high throughput screening [J].
Earnshaw, DL ;
Moore, KJ ;
Greenwood, CJ ;
Djaballah, H ;
Jurewicz, AJ ;
Murray, KJ ;
Pope, AJ .
JOURNAL OF BIOMOLECULAR SCREENING, 1999, 4 (05) :239-248
[8]   New antiviral therapies in the management of HCV infection [J].
Farnik, Harald ;
Zeuzem, Stefan .
ANTIVIRAL THERAPY, 2012, 17 (05) :771-783
[9]  
Frick DN, 2007, CURR ISSUES MOL BIOL, V9, P1
[10]   Graphene Oxide and Lipid Membranes: Interactions and Nanocomposite Structures [J].
Frost, Rickard ;
Jonsson, Gustav Edman ;
Chakarov, Dinko ;
Svedhem, Sofia ;
Kasemo, Bengt .
NANO LETTERS, 2012, 12 (07) :3356-3362